BFS
HRMY icon

Bare Financial Services’s Harmony Biosciences HRMY Stock Holding History

Bare Financial Services’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$837 Hold
23
– – ﹤0.01% 1443
2026
Q1 		$644 Buy
23
+8
+53% +$262 ﹤0.01% 1413
2025
Q4 		$561 Sell
15
-10
-40% -$329 ﹤0.01% 1329
2025
Q3 		$689 Hold
25
– – ﹤0.01% 1135
2025
Q2 		$790 Buy
+25
New +$804 ﹤0.01% 976

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bare Financial Services's HRMY Position: Q2 2026 in Review

Bare Financial Services held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 23 shares worth $837. The position accounts for ﹤0.01% of the portfolio, ranked #1443.

Bare Financial Services first reported a position in HRMY in Q2 2025 and has held it in 5 quarters since. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Bare Financial Services held 23 shares of Harmony Biosciences worth $837 as of Q2 2026.
  • Bare Financial Services left its Harmony Biosciences share count unchanged in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #1443 holding.
  • Bare Financial Services first reported a position in Harmony Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.